United States · FDA National Drug Code directory
Comirnaty
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0069-2528_0248cf65-e619-47eb-b9e2-355f9e797563
- Product NDC
- 0069-2528
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- COVID-19 Vaccine, mRNA
- Labeler
- Pfizer Laboratories Div Pfizer Inc
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250827 / 20270119
Source-listed ingredients
- BNT162B2 OMICRON (LP.8.1) — .042 mg/.418mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 SYRINGE, GLASS in 1 CARTON (0069-2528-10) / .418 mL in 1 SYRINGE, GLASS (0069-2528-01) · 0069-2528-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →